Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Jukich, PJ; McCarty, BJ; Surawicz, TS; Freels, S; Davis, FG
   Trends in incidence of primary brain tumors in the United States, 1985-1994
   NEURO-ONCOLOGY
   
   P.J. Jukich et al., "Trends in incidence of primary brain tumors in the United States, 1985-1994", NEURO-ONCOL, 3(3), 2001, pp. 141-151
2. Green, AJ; Bollen, AW; Berger, MS; Oksenberg, JR; Hauser, SL
   Multiple sclerosis and oligodendroglioma
   MULTIPLE SCLEROSIS
   
   A.J. Green et al., "Multiple sclerosis and oligodendroglioma", MULT SCLER, 7(4), 2001, pp. 269-273
3. Perry, A
   Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore
   ADVANCES IN ANATOMIC PATHOLOGY
   
   A. Perry, "Oligodendroglial neoplasms: Current concepts, misconceptions, and folklore", ADV ANAT PA, 8(4), 2001, pp. 183-199
4. Taddei, GL; Arganini, L; Raspollini, MR; Mennonna, P; Vannelli, B; Nesi, G; Buccoliero, AM
   Oligodendroglioma: HMB-45 positivity using catalyzed signal amplification method - An immunohistochemical (HMB-45, CD31, p53, Mib-1) and ultrastructural study
   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
   
   G.L. Taddei et al., "Oligodendroglioma: HMB-45 positivity using catalyzed signal amplification method - An immunohistochemical (HMB-45, CD31, p53, Mib-1) and ultrastructural study", APPL IMMUNO, 9(1), 2001, pp. 35-41
5. Tatter, SB
   Neurosurgical management of low- and intermediate-grade gliomas
   SEMINARS IN RADIATION ONCOLOGY
   
   S.B. Tatter, "Neurosurgical management of low- and intermediate-grade gliomas", SEM RAD ONC, 11(2), 2001, pp. 113-123
6. Lesser, GJ
   Chemotherapy of low-grade gliomas
   SEMINARS IN RADIATION ONCOLOGY
   
   G.J. Lesser, "Chemotherapy of low-grade gliomas", SEM RAD ONC, 11(2), 2001, pp. 138-144
7. Ljubimova, JY; Khazenzon, NM; Chen, ZT; Neyman, YI; Turner, L; Riedinger, MS; Black, KL
   Gene expression abnormalities in human glial tumors identified by gene array
   INTERNATIONAL JOURNAL OF ONCOLOGY
   
   J.Y. Ljubimova et al., "Gene expression abnormalities in human glial tumors identified by gene array", INT J ONCOL, 18(2), 2001, pp. 287-295
8. Johnson, MD; Jennings, MT; Toms, SA
   Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus
   PEDIATRIC NEUROSURGERY
   
   M.D. Johnson et al., "Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus", PED NEUROS, 34(6), 2001, pp. 301-305
9. Liigant, A; Kulla, A; Linnamagi, U; Asser, T; Kaasik, AE
   Survival of patients with primary CNS tumours in Estonia
   EUROPEAN JOURNAL OF CANCER
   
   A. Liigant et al., "Survival of patients with primary CNS tumours in Estonia", EUR J CANC, 37(15), 2001, pp. 1895-1903
10. Darling, JL; Thomas, DGT
    Response of short-term cultures derived from human malignant glioma to aziridinylbenzoquinone, etoposide and doxorubicin: an in vitro phase II trial
    ANTI-CANCER DRUGS
    
    J.L. Darling e D.G.T. Thomas, "Response of short-term cultures derived from human malignant glioma to aziridinylbenzoquinone, etoposide and doxorubicin: an in vitro phase II trial", ANTI-CANC D, 12(9), 2001, pp. 753-760
11. Hanna, CL; Saran, FH; Brewster, AE; Gollins, SW
    Extraneural metastases from primary cerebral glioma
    CLINICAL ONCOLOGY
    
    C.L. Hanna et al., "Extraneural metastases from primary cerebral glioma", CL ONCOL-UK, 13(4), 2001, pp. 309-309
12. Hosono, M; Machida, K; Matsui, T; Honda, N; Takahashi, T; Kashimada, A; Osada, H; Asano, T; Itoyama, S
    Oligodendroglioma with cystic component in infant
    COMPUTERIZED MEDICAL IMAGING AND GRAPHICS
    
    M. Hosono et al., "Oligodendroglioma with cystic component in infant", COMP MED IM, 25(4), 2001, pp. 361-365
13. Burger, PC; Minn, AY; Smith, JS; Borell, TJ; Jedlicka, AE; Huntley, BK; Goldthwaite, PT; Jenkins, RB; Feuerstein, BG
    Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections
    MODERN PATHOLOGY
    
    P.C. Burger et al., "Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections", MOD PATHOL, 14(9), 2001, pp. 842-853
14. Dai, C; Celestino, JC; Okada, Y; Louis, DN; Fuller, GN; Holland, EC
    PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
    GENES & DEVELOPMENT
    
    C. Dai et al., "PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo", GENE DEV, 15(15), 2001, pp. 1913-1925
15. Chinot, OL; Honore, S; Dufour, H; Barrie, M; Figarella-Branger, D; Muracciole, X; Braguer, D; Martin, PM; Grisoli, F
    Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy
    JOURNAL OF CLINICAL ONCOLOGY
    
    O.L. Chinot et al., "Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy", J CL ONCOL, 19(9), 2001, pp. 2449-2455
16. Broholm, H; Braendstrup, O; Lauritzen, M
    Nitric oxide synthase expression of oligodendrogliomas
    CLINICAL NEUROPATHOLOGY
    
    H. Broholm et al., "Nitric oxide synthase expression of oligodendrogliomas", CLIN NEUR, 20(6), 2001, pp. 233-238
17. Bergwitz, C; Bremer, B; Soudah, B; Mayr, B; Brabant, G
    Familial isolated parathyroid adenoma in a consanguineous family
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    
    C. Bergwitz et al., "Familial isolated parathyroid adenoma in a consanguineous family", J ENDOC INV, 24(5), 2001, pp. 349-355
18. Sakata, K; Hareyama, M; Komae, T; Shirato, H; Watanabe, O; Watarai, J; Takai, K; Yamada, S; Tsuchida, E; Sakai, K
    Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    
    K. Sakata et al., "Supratentorial astrocytomas and oligodendrogliomas treated in the MRI era", JPN J CLIN, 31(6), 2001, pp. 240-245
19. Forsyth, PA; Stewart, DA
    Oligodendrogliomas: The Achilles' heel of malignant gliomas
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    P.A. Forsyth e D.A. Stewart, "Oligodendrogliomas: The Achilles' heel of malignant gliomas", CAN J NEUR, 28(3), 2001, pp. 187-188
20. Fortin, D; Macdonald, DR; Stitt, L; Cairncross, JG
    PCV for oligodendroglial tumors: In search of prognostic factors for response and survival
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    
    D. Fortin et al., "PCV for oligodendroglial tumors: In search of prognostic factors for response and survival", CAN J NEUR, 28(3), 2001, pp. 215-223
21. Chaudhry, IH; O'Donovan, DG; Brenchley, PEC; Reid, H; Roberts, ISD
    Vascular endothelial growth factor expression correlates with tumour gradeand vascularity in gliomas
    HISTOPATHOLOGY
    
    I.H. Chaudhry et al., "Vascular endothelial growth factor expression correlates with tumour gradeand vascularity in gliomas", HISTOPATHOL, 39(4), 2001, pp. 409-415
22. Garcia-Ayllon, MS; Saez-Valero, J; Munoz-Delgado, E; Vidal, CJ
    Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma
    NEUROSCIENCE
    
    M.S. Garcia-Ayllon et al., "Identification of hybrid cholinesterase forms consisting of acetyl- and butyrylcholinesterase subunits in human glioma", NEUROSCIENC, 107(2), 2001, pp. 199-208
23. Wharton, SB; Chan, KK; Anderson, JR; Stoeber, K; Williams, GH
    Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    S.B. Wharton et al., "Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis", NEUROP AP N, 27(4), 2001, pp. 305-313
24. Xu, XY; Joh, HD; Pin, S; Schiller, NI; Prange, C; Burger, PC; Schiller, MR
    Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype
    CANCER LETTERS
    
    X.Y. Xu et al., "Expression of multiple larger-sized transcripts for several genes in oligodendrogliomas: potential markers for glioma subtype", CANCER LETT, 171(1), 2001, pp. 67-77
25. Jenkins, RB; Curran, W; Scott, CB; Cairncross, G
    Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    R.B. Jenkins et al., "Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group", AM J CL ONC, 24(5), 2001, pp. 506-508
26. Vaquero, J; Zurita, M; Morales, C; Coca, S
    Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas
    BRITISH JOURNAL OF NEUROSURGERY
    
    J. Vaquero et al., "Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas", BR J NEUROS, 15(3), 2001, pp. 247-250
27. Choudhari, KA; McLorinan, GC; Byrnes, DP
    Spontaneous regression of a primary cerebral tumour following postoperative middle cerebral artery territory infarction
    BRITISH JOURNAL OF NEUROSURGERY
    
    K.A. Choudhari et al., "Spontaneous regression of a primary cerebral tumour following postoperative middle cerebral artery territory infarction", BR J NEUROS, 15(2), 2001, pp. 177-180
28. Miettinen, HE; Paunu, N; Rantala, I; Kalimo, H; Paljarvi, L; Helin, H; Haapasalo, H
    Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: A study by novel tumor microarray technique
    JOURNAL OF NEURO-ONCOLOGY
    
    H.E. Miettinen et al., "Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: A study by novel tumor microarray technique", J NEURO-ONC, 55(1), 2001, pp. 29-37
29. Diabira, S; Rousselet, MC; Gamelin, E; Soulier, P; Jadaud, E; Menei, P
    PCV chemotherapy for oligodendroglioma: response analyzed on T2 Weighted-MRI
    JOURNAL OF NEURO-ONCOLOGY
    
    S. Diabira et al., "PCV chemotherapy for oligodendroglioma: response analyzed on T2 Weighted-MRI", J NEURO-ONC, 55(1), 2001, pp. 45-50
30. Cervio, A; Piedimonte, F; Salaberry, J; Alcorta, SC; Salvat, J; Diez, B; Sevlever, G
    Bone metastases from secondary glioblastoma multiforme: A case report
    JOURNAL OF NEURO-ONCOLOGY
    
    A. Cervio et al., "Bone metastases from secondary glioblastoma multiforme: A case report", J NEURO-ONC, 52(2), 2001, pp. 141-148
31. Bredel, M
    Anticancer drug resistance in primary human brain tumors
    BRAIN RESEARCH REVIEWS
    
    M. Bredel, "Anticancer drug resistance in primary human brain tumors", BRAIN RES R, 35(2), 2001, pp. 161-204
32. Perry, A; Scheithauer, BW; Szczesniak, DM; Atkinson, JLD; Wald, JT; Hammak, MD
    Combined oligodendroglioma/pleomorphic xanthoastrocytoma: A probable collision tumor: Case report
    NEUROSURGERY
    
    A. Perry et al., "Combined oligodendroglioma/pleomorphic xanthoastrocytoma: A probable collision tumor: Case report", NEUROSURGER, 48(6), 2001, pp. 1358-1361
33. Robinson, S; Cohen, M; Prayson, R; Ransohoff, RM; Tabrizi, N; Miller, RH
    Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas
    NEUROSURGERY
    
    S. Robinson et al., "Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas", NEUROSURGER, 48(4), 2001, pp. 864-873
34. Peterson, K; DeAngelis, LM
    Weighing the benefits and risks of radiation therapy for low-grade glioma
    NEUROLOGY
    
    K. Peterson e L.M. DeAngelis, "Weighing the benefits and risks of radiation therapy for low-grade glioma", NEUROLOGY, 56(10), 2001, pp. 1255-1256
35. Kappelle, AC; Postma, TJ; Taphoorn, MJB; Groeneveld, GJ; van den Bent, MJ; van Groeningen, CJ; Zonnenberg, BA; Sneeuw, KCA; Heimans, JJ
    PCV chemotherapy for recurrent glioblastoma multiforme
    NEUROLOGY
    
    A.C. Kappelle et al., "PCV chemotherapy for recurrent glioblastoma multiforme", NEUROLOGY, 56(1), 2001, pp. 118-120
36. Graus, F; Cerda, M; Piquer, J; Reynes, G; Santos, M
    Recommedations on the multidisciplinary management in patients with malignant glioma
    MEDICINA CLINICA
    
    F. Graus et al., "Recommedations on the multidisciplinary management in patients with malignant glioma", MED CLIN, 116(7), 2001, pp. 271-275
37. Holodny, AI; Schwartz, TH; Ollenschleger, M; Liu, WC; Schulder, M
    Tumor involvement of the corticospinal tract: diffusion magnetic resonancetractography with intraoperative correlation - Case illustration
    JOURNAL OF NEUROSURGERY
    
    A.I. Holodny et al., "Tumor involvement of the corticospinal tract: diffusion magnetic resonancetractography with intraoperative correlation - Case illustration", J NEUROSURG, 95(6), 2001, pp. 1082-1082
38. Keles, GE; Lamborn, KR; Berger, MS
    Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
    JOURNAL OF NEUROSURGERY
    
    G.E. Keles et al., "Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome", J NEUROSURG, 95(5), 2001, pp. 735-745
39. Dong, SM; Pang, JCS; Poon, WS; Hu, J; To, KF; Chang, AR; Ng, HK
    Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    S.M. Dong et al., "Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors", J NE EXP NE, 60(8), 2001, pp. 808-816
40. Giannini, C; Scheithauer, BW; Weaver, AL; Burger, PC; Kros, JM; Mork, S; Graeber, MB; Bauserman, S; Buckner, JC; Burton, J; Riepe, R; Tazelaar, HD; Nascimento, AG; Crotty, T; Keeney, GL; Pernicone, P; Altermatt, H
    Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    C. Giannini et al., "Oligodendrogliomas: Reproducibility and prognostic value of histologic diagnosis and grading", J NE EXP NE, 60(3), 2001, pp. 248-262
41. Wolter, M; Reifenberger, J; Blaschke, B; Ichimura, K; Schmidt, EE; Collins, VP; Reifenberger, G
    Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16(INK4a)), p14(ARF), and CDKN2B (MTS2, p15(INK4b)) tumor suppressor genes
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    M. Wolter et al., "Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16(INK4a)), p14(ARF), and CDKN2B (MTS2, p15(INK4b)) tumor suppressor genes", J NE EXP NE, 60(12), 2001, pp. 1170-1180
42. Watanabe, T; Yokoo, H; Yokoo, M; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    T. Watanabe et al., "Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas", J NE EXP NE, 60(12), 2001, pp. 1181-1189
43. Birner, P; Gatterbauer, B; Oberhuber, G; Schindl, M; Rossler, K; Prodinger, A; Budka, H; Hainfellner, JA
    Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas - Itsimpact on prognosis and on neoangiogenesis
    CANCER
    
    P. Birner et al., "Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas - Itsimpact on prognosis and on neoangiogenesis", CANCER, 92(1), 2001, pp. 165-171
44. Watanabe, T; Nakamura, M; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Promoter hypermethylation and homozygous deletion of the p14(ARF) and p16(INK4a) genes in oligodendrogliomas
    ACTA NEUROPATHOLOGICA
    
    T. Watanabe et al., "Promoter hypermethylation and homozygous deletion of the p14(ARF) and p16(INK4a) genes in oligodendrogliomas", ACT NEUROP, 101(3), 2001, pp. 185-189
45. Lopez-Rios, F; Alberti, N; Ballestin, C; Perez-Barrios, A; de Agustin, P
    Extracranial metastasis of a glioma: Diagnosis by fine-needle aspiration and immunocytochemistry
    DIAGNOSTIC CYTOPATHOLOGY
    
    F. Lopez-Rios et al., "Extracranial metastasis of a glioma: Diagnosis by fine-needle aspiration and immunocytochemistry", DIAGN CYTOP, 23(1), 2000, pp. 43-45
46. Cirak, B; Caksen, H; Ugras, S; Unal, O
    Primary leptomeningeal astrocytoma in a child
    PEDIATRICS INTERNATIONAL
    
    B. Cirak et al., "Primary leptomeningeal astrocytoma in a child", PEDIATR INT, 42(4), 2000, pp. 389-391
47. Smith, JS; Jenkins, RB
    Genetic alterations in adult diffuse glioma: Occurrence, significance, andprognostic implications
    FRONTIERS IN BIOSCIENCE
    
    J.S. Smith e R.B. Jenkins, "Genetic alterations in adult diffuse glioma: Occurrence, significance, andprognostic implications", FRONT BIOSC, 5, 2000, pp. D213-D231
48. Daneyemez, M; Baysefer, A; Can, C; Timurkaynak, E
    Multiple oligodendroglioma: Case report
    MINIMALLY INVASIVE NEUROSURGERY
    
    M. Daneyemez et al., "Multiple oligodendroglioma: Case report", MIN IN NEUR, 43(1), 2000, pp. 51-52
49. Chorny, JA; Evans, LC; Kleinschmidt-DeMasters, BK
    Cerebral granular cell astrocytomas: a Mib-1, bcl-2, and telomerase study
    CLINICAL NEUROPATHOLOGY
    
    J.A. Chorny et al., "Cerebral granular cell astrocytomas: a Mib-1, bcl-2, and telomerase study", CLIN NEUR, 19(4), 2000, pp. 170-179
50. Shintaku, M; Itoh, M
    Astrocytoma with angiamatoid vascular proliferation ("angiomatous astrocytoma")
    CLINICAL NEUROPATHOLOGY
    
    M. Shintaku e M. Itoh, "Astrocytoma with angiamatoid vascular proliferation ("angiomatous astrocytoma")", CLIN NEUR, 19(4), 2000, pp. 180-185
51. Schlegel, U
    Recent developments in brain tumor therapy
    NERVENHEILKUNDE
    
    U. Schlegel, "Recent developments in brain tumor therapy", NERVENHEILK, 19(1), 2000, pp. 14-20
52. Bauman, GS; Ino, Y; Ueki, K; Zlatescu, MC; Fisher, BJ; Macdonald, DR; Stitt, L; Louis, DN; Cairncross, JG
    Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    G.S. Bauman et al., "Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas", INT J RAD O, 48(3), 2000, pp. 825-830
53. Derlon, JM; Chapon, F; Noel, MH; Khouri, S; Benali, K; Petit-Taboue, MC; Houtteville, JP; Chajari, MH; Bouvard, G
    Non-invasive grading of oligodendrogliomas: correlations between in vivo metabolic pattern and histopathology
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    
    J.M. Derlon et al., "Non-invasive grading of oligodendrogliomas: correlations between in vivo metabolic pattern and histopathology", EUR J NUCL, 27(7), 2000, pp. 778-787
54. Streffer, J; Schabet, M; Bamberg, M; Grote, EH; Meyermann, R; Voigt, K; Dichgans, J; Weller, M
    A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors
    JOURNAL OF NEUROLOGY
    
    J. Streffer et al., "A role for preirradiation PCV chemotherapy for oligodendroglial brain tumors", J NEUROL, 247(4), 2000, pp. 297-302
55. Miettinen, HE; Jarvinen, TAH; Kellner, U; Kauraniemi, P; Parwaresch, R; Rantala, I; Kalimo, H; Paljarvi, L; Isola, J; Haapasalo, H
    High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    H.E. Miettinen et al., "High topoisomerase II alpha expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas", NEUROP AP N, 26(6), 2000, pp. 504-512
56. Varlet, P; Guillamo, JS; Nataf, F; Koziak, M; Beuvon, F; Fallet, C; Daumas-Duport, C
    Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    P. Varlet et al., "Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival", NEUROP AP N, 26(4), 2000, pp. 379-389
57. Dickinson, PJ; Keel, MK; Higgins, RJ; Koblik, PD; LeCouteur, RA; Naydan, DK; Bollen, AW; Vernau, W
    Clinical and pathologic features of oligodendrogliomas in two cats
    VETERINARY PATHOLOGY
    
    P.J. Dickinson et al., "Clinical and pathologic features of oligodendrogliomas in two cats", VET PATH, 37(2), 2000, pp. 160-167
58. Allam, A; Radwi, A; El Weshi, A; Hassounah, M
    Oligodendroglioma: An analysis of prognostic factors and treatment results
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    
    A. Allam et al., "Oligodendroglioma: An analysis of prognostic factors and treatment results", AM J CL ONC, 23(2), 2000, pp. 170-175
59. Strik, HM; Weller, M; Frank, B; Hermisson, M; Deininger, MH; Dichgans, J; Meyermann, R
    Heat shock protein expression in human gliomas
    ANTICANCER RESEARCH
    
    H.M. Strik et al., "Heat shock protein expression in human gliomas", ANTICANC R, 20(6B), 2000, pp. 4457-4462
60. Tsujimoto, T; Mochizuchi, S; Iwadate, Y; Namba, H; Nagai, M; Kawamoto, T; Sunahara, M; Yamaura, A; Nakagawara, A; Sakiyama, S; Tagawa, M
    The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3
    ANTICANCER RESEARCH
    
    T. Tsujimoto et al., "The p73 gene is not mutated in oligodendrogliomas which frequently have a deleted region at chromosome 1p36.3", ANTICANC R, 20(4), 2000, pp. 2495-2497
61. Daumas-Duport, C; Beuvon, F; Varlet, P; Fallet-Bianco, C
    Gliomas : WHO and Sainte-Anne Hospital classification
    ANNALES DE PATHOLOGIE
    
    C. Daumas-Duport et al., "Gliomas : WHO and Sainte-Anne Hospital classification", ANN PATHOL, 20(5), 2000, pp. 413-428
62. Krinke, GJ; Kaufmann, W; Mahrous, AT; Schaetti, P
    Morphologic characterization of spontaneous nervous system tumors in mice and rats
    TOXICOLOGIC PATHOLOGY
    
    G.J. Krinke et al., "Morphologic characterization of spontaneous nervous system tumors in mice and rats", TOX PATHOL, 28(1), 2000, pp. 178-192
63. Korshunov, A; Golanov, A
    The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases
    JOURNAL OF NEURO-ONCOLOGY
    
    A. Korshunov e A. Golanov, "The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases", J NEURO-ONC, 48(1), 2000, pp. 13-19
64. Cillekens, JMJ; Belien, JAM; van der Valk, P; Faes, TJC; van Diest, PJ; Broeckaert, MAM; Kralendonk, JH; Kamphorst, W
    A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers
    JOURNAL OF NEURO-ONCOLOGY
    
    J.M.J. Cillekens et al., "A histopathological contribution to supratentorial glioma grading, definition of mixed gliomas and recognition of low grade glioma with Rosenthal fibers", J NEURO-ONC, 46(1), 2000, pp. 23-43
65. Akutsu, H; Shibata, Y; Okazaki, M; Hyodo, A; Matsumura, A
    Intramedullary clear cell ependymoma in the cervical spinal cord: Case report
    NEUROSURGERY
    
    H. Akutsu et al., "Intramedullary clear cell ependymoma in the cervical spinal cord: Case report", NEUROSURGER, 47(6), 2000, pp. 1434-1437
66. Vaquero, J; Zurita, M; Coca, S; Oya, S; Morales, C
    Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas
    SURGICAL NEUROLOGY
    
    J. Vaquero et al., "Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas", SURG NEUROL, 54(3), 2000, pp. 229-234
67. Olson, JD; Riedel, E; DeAngelis, LM
    Long-term outcome of low-grade oligodendroglioma and mixed glioma
    NEUROLOGY
    
    J.D. Olson et al., "Long-term outcome of low-grade oligodendroglioma and mixed glioma", NEUROLOGY, 54(7), 2000, pp. 1442-1448
68. Godard, J; Viennet, G; Raul, JS; Plouvier, E; Miny, J; Jacquet, G; Czorny, A
    Intramedullary spread of a cerebral oligodendroglioma. Two case reports
    NEUROCHIRURGIE
    
    J. Godard et al., "Intramedullary spread of a cerebral oligodendroglioma. Two case reports", NEUROCHIRE, 46(6), 2000, pp. 558-562
69. Ino, Y; Zlatescu, MC; Sasaki, H; MacDonald, DR; Stemmer-Rachamimov, AO; Jhung, S; Ramsay, DA; von Deimling, A; Louis, DN; Cairncross, JG
    Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss
    JOURNAL OF NEUROSURGERY
    
    Y. Ino et al., "Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss", J NEUROSURG, 92(6), 2000, pp. 983-990
70. Jeuken, JWM; Sprenger, SHE; Wesseling, P; Bernsen, HJJA; Suijkerbuijk, RF; Roelofs, F; Macville, MVE; Gilhuis, HJ; van Overbeeke, JJ; Boerman, RH
    Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization
    JOURNAL OF NEUROSURGERY
    
    J.W.M. Jeuken et al., "Genetic reflection of glioblastoma biopsy material in xenografts: characterization of 11 glioblastoma xenograft lines by comparative genomic hybridization", J NEUROSURG, 92(4), 2000, pp. 652-658
71. Gilmer-Hill, HS; Ellis, WG; Imbesi, SG; Boggan, JE
    Spinal oligodendroglioma with gliomatosis in a child - Case report
    JOURNAL OF NEUROSURGERY
    
    H.S. Gilmer-Hill et al., "Spinal oligodendroglioma with gliomatosis in a child - Case report", J NEUROSURG, 92(1), 2000, pp. 109-113
72. Kros, JM; Waarsenburg, N; Hayes, DP; Hop, WCJ; van Dekken, H
    Cytogenetic analysis of gemistocytic cells in gliomas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    J.M. Kros et al., "Cytogenetic analysis of gemistocytic cells in gliomas", J NE EXP NE, 59(8), 2000, pp. 679-686
73. Smith, JS; Wang, XY; Qian, JQ; Hosek, SM; Scheithauer, BW; Jenkins, RB; James, CD
    Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    J.S. Smith et al., "Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features", J NE EXP NE, 59(6), 2000, pp. 495-503
74. Kastenbauer, S; Danek, A; Klein, W; Yousry, TA; Bise, K; Reifenberger, G; Pfister, HW
    Primary diffuse leptomeningeal gliomatosis: unusual MRI with non-enhancingnodular lesions on the cerebellar surface and spinal leptomeningeal enhancement
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    S. Kastenbauer et al., "Primary diffuse leptomeningeal gliomatosis: unusual MRI with non-enhancingnodular lesions on the cerebellar surface and spinal leptomeningeal enhancement", J NE NE PSY, 69(3), 2000, pp. 385-388
75. McLendon, RE; Wikstrand, CJ; Matthews, MR; Al-Baradei, R; Bigner, SH; Bigner, DD
    Glioma-associated antigen expression in oligodendroglial neoplasms: Tenascin and epidermal growth factor receptor
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    
    R.E. McLendon et al., "Glioma-associated antigen expression in oligodendroglial neoplasms: Tenascin and epidermal growth factor receptor", J HIST CYTO, 48(8), 2000, pp. 1103-1110
76. Nutt, CL; Noble, M; Chambers, AF; Cairncross, JG
    Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy
    CANCER RESEARCH
    
    C.L. Nutt et al., "Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy", CANCER RES, 60(17), 2000, pp. 4812-4818
77. Reis, JS; Faoro, LN; Carrilho, C; Bleggi-Torres, LF; Schmitt, FC
    Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization Grade 2 oligodendroglioma
    CANCER
    
    J.S. Reis et al., "Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization Grade 2 oligodendroglioma", CANCER, 88(4), 2000, pp. 862-869
78. Galanis, E; Buckner, J
    Chemotherapy for high-grade gliomas
    BRITISH JOURNAL OF CANCER
    
    E. Galanis e J. Buckner, "Chemotherapy for high-grade gliomas", BR J CANC, 82(8), 2000, pp. 1371-1380
79. Deininger, MH; Meyermann, R; Trautmann, K; Morgalla, M; Duffner, F; Grote, EH; Wickboldt, J; Schluesener, HJ
    Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression
    BRAIN RESEARCH
    
    M.H. Deininger et al., "Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression", BRAIN RES, 885(1), 2000, pp. 111-116
80. Deininger, MH; Meyermann, R; Trautmann, K; Duffner, F; Grote, EH; Wickboldt, J; Schluesener, HJ
    Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression
    BRAIN RESEARCH
    
    M.H. Deininger et al., "Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression", BRAIN RES, 882(1-2), 2000, pp. 1-8
81. Holland, CT; Charles, JA; Smith, SH; Cortaville, PE
    Hemihyperaesthesia and hyperresponsiveness resembling central pain syndrome in a dog with a forebrain oligodendroglioma
    AUSTRALIAN VETERINARY JOURNAL
    
    C.T. Holland et al., "Hemihyperaesthesia and hyperresponsiveness resembling central pain syndrome in a dog with a forebrain oligodendroglioma", AUST VET J, 78(10), 2000, pp. 676-680
82. Chretien, F; Boche, D; de la Grandmaison, GL; Ereau, T; Mikol, J; Hurtrel, M; Hurtrel, B; Gray, F
    Progressive multifocal leukoencephalopathy and oligodendroglioma in a monkey co-infected by simian immunodeficiency virus and simian virus 40
    ACTA NEUROPATHOLOGICA
    
    F. Chretien et al., "Progressive multifocal leukoencephalopathy and oligodendroglioma in a monkey co-infected by simian immunodeficiency virus and simian virus 40", ACT NEUROP, 100(3), 2000, pp. 332-336
83. Dehghani, F; Maronde, E; Schachenmayr, W; Korf, HW
    Neurofilament H immunoreaction in oligodendrogliomas as demonstrated by a new polyclonal antibody
    ACTA NEUROPATHOLOGICA
    
    F. Dehghani et al., "Neurofilament H immunoreaction in oligodendrogliomas as demonstrated by a new polyclonal antibody", ACT NEUROP, 100(2), 2000, pp. 122-130
84. Evliyaoglu, C; Carroll, R; Folkerth, R; Bello, L; Bruns, DE; Black, PM
    Parathyroid hormone-related protein and its receptor in human glial tumors
    ACTA NEUROCHIRURGICA
    
    C. Evliyaoglu et al., "Parathyroid hormone-related protein and its receptor in human glial tumors", ACT NEUROCH, 142(8), 2000, pp. 871-878
85. Chou, YY; Lee, CC; Chen, TJ; Wei, CP
    Atypical central neurocytoma: Report of a case
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    
    Y.Y. Chou et al., "Atypical central neurocytoma: Report of a case", J FORMOS ME, 98(8), 1999, pp. 573-577
86. Uchida, K; Muranaka, M; Murakami, T; Yamaguchi, R; Tateyama, S
    Spinal oligodendroglioma with diffuse arachnoidal dissemination in a Japanese Black heifer
    JOURNAL OF VETERINARY MEDICAL SCIENCE
    
    K. Uchida et al., "Spinal oligodendroglioma with diffuse arachnoidal dissemination in a Japanese Black heifer", J VET MED S, 61(12), 1999, pp. 1323-1326
87. Zhao, M; Takata, T; Kudo, Y; Sato, S; Ogawa, I; Wakida, K; Uchida, T; Nikai, H
    Biosynthesis of glycosaminoglycans and aggrecan by tumor cells in salivarypleomorphic adenoma: ultrastructural evidence
    JOURNAL OF ORAL PATHOLOGY & MEDICINE
    
    M. Zhao et al., "Biosynthesis of glycosaminoglycans and aggrecan by tumor cells in salivarypleomorphic adenoma: ultrastructural evidence", J ORAL PATH, 28(10), 1999, pp. 442-450
88. Weil, RJ; Wu, YY; Vortmeyer, AO; Moon, YW; Delgado, RM; Fuller, BG; Lonser, RR; Remaley, AT; Zhuang, ZP
    Telomerase activity in microdissected human gliomas
    MODERN PATHOLOGY
    
    R.J. Weil et al., "Telomerase activity in microdissected human gliomas", MOD PATHOL, 12(1), 1999, pp. 41-46
89. Broholm, H; Bols, B; Heegaard, S; Braendstrup, O
    Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas
    CLINICAL NEUROPATHOLOGY
    
    H. Broholm et al., "Immunohistochemical investigation of p53 and EGFR expression of oligodendrogliomas", CLIN NEUR, 18(4), 1999, pp. 176-180
90. Saito, A; Nakazato, Y
    Evaluation of malignant features in oligodendroglial tumors
    CLINICAL NEUROPATHOLOGY
    
    A. Saito e Y. Nakazato, "Evaluation of malignant features in oligodendroglial tumors", CLIN NEUR, 18(2), 1999, pp. 61-73
91. Hagel, C; Krog, B; Laas, R; Stavrou, DK
    Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    
    C. Hagel et al., "Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas", J EXP CL C, 18(3), 1999, pp. 305-309
92. Bauman, G; Lote, K; Larson, D; Stalpers, L; Leighton, C; Fisher, B; Wara, W; MacDonald, D; Stitt, L; Cairncross, JG
    Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    
    G. Bauman et al., "Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis", INT J RAD O, 45(4), 1999, pp. 923-929
93. Vajtai, I; Mucsi, Z; Varga, Z; Bodi, I
    Signet-ring cell ependymoma: Case report with implications for pathogenesis and differential diagnosis
    PATHOLOGY RESEARCH AND PRACTICE
    
    I. Vajtai et al., "Signet-ring cell ependymoma: Case report with implications for pathogenesis and differential diagnosis", PATH RES PR, 195(12), 1999, pp. 853-858
94. Al-Sarraj, ST
    Molecular genetic analysis of non-astrocytic gliomas
    HISTOPATHOLOGY
    
    S.T. Al-Sarraj, "Molecular genetic analysis of non-astrocytic gliomas", HISTOPATHOL, 34(4), 1999, pp. 370-371
95. Hagel, C; Stavrou, DK
    CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    C. Hagel e D.K. Stavrou, "CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue", NEUROP AP N, 25(4), 1999, pp. 313-318
96. Park, SH; Ostrzega, N; Akers, MA; Vinters, HV
    Intraventricular neurocytoma with prominent myelin figures
    ULTRASTRUCTURAL PATHOLOGY
    
    S.H. Park et al., "Intraventricular neurocytoma with prominent myelin figures", ULTRA PATH, 23(5), 1999, pp. 311-317
97. Luider, TM; Kros, JM; Smitt, PAES; van den Bent, MJ; Vecht, CJ
    Glial fibrillary acidic protein and its fragments discriminate astrocytomafrom oligodendroglioma
    ELECTROPHORESIS
    
    T.M. Luider et al., "Glial fibrillary acidic protein and its fragments discriminate astrocytomafrom oligodendroglioma", ELECTROPHOR, 20(4-5), 1999, pp. 1087-1091
98. Schiffer, D; Bosone, I; Dutto, A; Di Vito, N; Chio, A
    The prognostic role of vessel productive changes and vessel density in oligodendroglioma
    JOURNAL OF NEURO-ONCOLOGY
    
    D. Schiffer et al., "The prognostic role of vessel productive changes and vessel density in oligodendroglioma", J NEURO-ONC, 44(2), 1999, pp. 99-107
99. Jeremic, B; Shibamoto, Y; Grujicic, D; Milicic, B; Stojanovic, M; Nikolic, N; Dagovic, A; Aleksandrovic, J
    Combined treatment modality for anaplastic oligodendroglioma: A phase II study
    JOURNAL OF NEURO-ONCOLOGY
    
    B. Jeremic et al., "Combined treatment modality for anaplastic oligodendroglioma: A phase II study", J NEURO-ONC, 43(2), 1999, pp. 179-185
100. Mineura, K; Shioya, H; Kowada, M; Ogawa, T; Hatazawa, J; Uemura, K
     Blood flow and metabolism of oligodendrogliomas: A positron emission tomography study with kinetic analysis of F-18-fluorodeoxyglucose
     JOURNAL OF NEURO-ONCOLOGY
     
     K. Mineura et al., "Blood flow and metabolism of oligodendrogliomas: A positron emission tomography study with kinetic analysis of F-18-fluorodeoxyglucose", J NEURO-ONC, 43(1), 1999, pp. 49-57